Codes / ICD10CM / P83.4

P83.4 Breast engorgement of newborn

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Breast engorgement of newborn (P83.4)

Summary

Breast engorgement of the newborn is a transient condition characterized by swelling and firmness of the neonatal breast tissue. It occurs due to hormonal influences from the mother and typically resolves without intervention. This condition is distinct from other neonatal breast abnormalities and is a normal physiological response in some infants.

Causes

The primary cause is the transfer of maternal hormones, particularly estrogen and prolactin, across the placenta during pregnancy. These hormones stimulate breast tissue development in the newborn. After birth, the withdrawal of maternal hormones leads to temporary engorgement as the infant's body adjusts. No external factors are typically involved.

Risk Factors

  • Exposure to maternal hormones in utero
  • Normal physiological variation in neonatal hormone levels
  • No specific maternal or infant risk factors are associated with this condition

Symptoms

  • Swelling or enlargement of one or both breasts
  • Firmness to the touch
  • Possible mild discoloration of the overlying skin
  • No pain or tenderness is typically reported
  • May persist for several days to weeks

Diagnosis

Diagnosis is made through clinical examination of the newborn's breast tissue. No laboratory tests or imaging are required. The healthcare provider will assess the size, firmness, and appearance of the breasts to confirm the diagnosis. Documentation should note the absence of other abnormalities, such as discharge or infection.

Treatment Options

Treatment is generally not necessary, as the condition resolves spontaneously. If the infant appears uncomfortable, gentle handling or observation may be recommended. No medications or interventions are indicated for this benign condition.

Prognosis and Follow-Up

The prognosis is excellent, with complete resolution expected within a few weeks. No long-term follow-up is typically required unless symptoms persist beyond the expected timeframe or other concerns arise. Parents or caregivers should be reassured that this is a normal and temporary finding.

Complications

Complications are rare. In some cases, minor bruising or skin irritation may occur due to swelling, but these are self-limiting. There is no risk of infection or long-term breast tissue damage associated with this condition.

Lifestyle & Prevention

No specific lifestyle modifications or preventive measures are needed. This is a natural physiological process that does not require intervention. Educating caregivers about the benign nature of the condition can help reduce unnecessary concern.

When to Seek Professional Help

Seek medical attention if the breast tissue shows signs of infection, such as redness, warmth, or discharge, or if the infant appears unusually distressed. Persistent swelling beyond six weeks or asymmetrical breast development may warrant further evaluation to rule out other conditions.

Tips for Medical Coders

When coding P83.4, ensure documentation clearly describes the breast engorgement as a transient, physiological finding in the newborn. Differentiate this from other breast conditions, such as galactorrhea or infection, which require separate coding. Note that this code is specific to newborns and should not be used for older infants or children.

Book a walkthrough

P83.4 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.